We have a lot of work to do, and we do need the support of the NIH [National Institutes of Health] and sometimes pharmaceutical companies in order to get the testing done, she says
Am J Obstet Gynecol 231(2):196210
Read clinical review GLP-1 receptor agonists such as semaglutide affect dopamine reward circuits in the brain, reducing impulsive behaviors around food, alcohol, and other compulsive habits
This is its greatest strength as a research tool
Mens resultaterne for eksempelvis Alzheimers har vret skuffende, mener han, at belnningssystemet og afhngighed er et af de mest lovende omrder for fremtidens brug af GLP-1
Add a medication built to slow things down, and a "slow stomach" can tip over into a paralyzed one